Inari Medical Inc expected to post a loss of 15 cents a share - Earnings Preview

Inari Medical

26/07/2024 22:11

* Inari Medical Inc  NARI.OQ   NARI.O  is expected to show a
rise
in quarterly revenue when it reports  results on July 30 for the
period ending June 30 2024
    * The Irvine California-based  company is expected to report
a
20.8% increase in revenue to $143.749 million from $119.01
million a year ago, according to the mean estimate from 11
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Inari Medical Inc is for
a
loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inari
Medical Inc
is $65.00​, above​ its last closing price of $55.20. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.22       -0.20      -0.22     Missed  -9.9
 Dec. 31 0001  0.00        0.01       -0.08     Missed  -1,433
                                                        .3
 Sep. 30 2023  0.00        0.00       0.05      Beat    1,026.
                                                        1​
 Jun. 30 2023  -0.13       -0.13      0.04      Beat    131.6
 ​​Jan.        -0.22       -0.23      -0.04     Beat    82.3
 1 0001                                                 
 Dec. 31 2022  -0.17       -0.17      -0.11     Beat    35.8​
 Sep. 30 2022  -0.26       -0.25      -0.19     Beat    25.1
 Jun. 30 2022  -0.23       -0.23      -0.19     Beat    17.4
 This summary was machine generated July 26 at 21:11 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)